ReviewMikrochimica acta2026
Advances in optical and electrochemical aptasensors for tumor biomarker alpha-fetoprotein.
Review in Mikrochimica acta, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Flexible Multimodal Neural Probe with Integrated Three-Electrode Aptameric Sensing for In Vivo Monitoring of Dopamine Dynamics and Neural Activity.ACS chemical neuroscience · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
Abstract
Alpha-fetoprotein (AFP) is a critical tumor biomarker associated with various diseases, and its accurate determination is very important for clinical detection. However, the conventional techniques for detecting AFP have drawbacks such as complex sample pretreatment procedures, complicated and time-consuming operations, reliance on expensive and bulky instruments, and the need for skilled professionals, thus limiting their applications. The emergence of aptamers provides a novel and unique probe for establishment of aptasensors, effectively avoiding the aforementioned shortcomings. As a result, the application of aptamers for AFP detection has garnered increasing attention and became one of the research hotspots in recent years. In this review, the progress of aptamer selection against AFP is presented initially. Subsequently, we systematically summarize the latest advancements and trends in optical and electrochemical aptasensors for AFP detection, focusing on known AFP aptamer sequences and methods that use aptamers, such as fluorescence, surface-enhanced Raman scattering (SERS), chemiluminescence (CL), and photoelectrochemistry (PEC). In addition, challenges and future directions in this field are discussed to provide insights for the development of efficient and accurate AFP detection technologies.
Indexed as
Identifiers
41575587What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.